TC BioPharm (TCBP) Stock Price
$2.5 0%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
1 -
Technical
2
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on TC BioPharm, AI stock picks, stock alerts and much more.
TCBP AI Stock Analysis
AI stock analysis for TCBP is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like TC BioPharm (TCBP) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
TC BioPharm (TCBP) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of TC BioPharm (TCBP), currently trading at $2.5, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About TCBP
-
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on developing immunotherapy products based on its allogeneic gamma delta T cell platform.
-
Symbol
TCBP
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
385
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
TCBP Alternative Data
Web Traffic
TC BioPharm receives an estimated 4191 monthly visitors to tcbiopharm.com.
-
Web Traffic
4191
-
Change from Previous Month
21.4%
-
3 Month Change
17.3%
-
YoY Change
17.3%
News Mentions
TC BioPharm was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
TC BioPharm has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
TC BioPharm has 923 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.8% over the last month.
-
Twitter Followers
923
-
Daily Change
0.2%
-
1 Month Change
0.8%
-
3 Month Change
1.4%
LinkedIn Followers
7,728 are following TC BioPharm on LinkedIn, up by 1% over the last month.
-
LinkedIn Followers
7728
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
2.6%
Job Postings
TC BioPharm currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, TC BioPharm has 54 employees, up by 1.9% over the last month.
-
LinkedIn Employees
54
-
Daily Change
0%
-
1 Month Change
1.9%
-
3 Month Change
3.8%
TCBP Financials
TCBP Key Metrics
-
Total Revenue
$0
-
Net Income
-$2M
-
Earnings per Share
$0
-
Free cash flow
-$2.8M
-
EBITDA
-$1.9M
-
EBITDA Ratio
0
-
Total Assets
$6.9M
TCBP 2-year Revenue & Income
TCBP 2-year Free Cash Flow
TCBP Technicals
TCBP SMA
TCBP RSI
FAQ
What's the current price of TC BioPharm (TCBP) Stock?
The price of an TC BioPharm (TCBP) share is $2.5.
What's the market cap of TC BioPharm?
The current market cap of TC BioPharm is 385.
Should I buy or sell TCBP?
TC BioPharm exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is TC BioPharm a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in TC BioPharm stock. There are several bearish signals and market challenges that could negatively impact TC BioPharm's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy TC BioPharm (TCBP) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy TC BioPharm stock right now, as the outlook appears bearish.
What are some stocks similar to TC BioPharm (TCBP) that investors often compare it to?
TC BioPharm (TCBP) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for TC BioPharm's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast TC BioPharm's stock price to be around $2.35 in 2026. Starting from the current price of $2.5, this represents a 6.1% change in price, indicating a bearish outlook for the stock.
How to buy TC BioPharm (TCBP) Stock?
TC BioPharm stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy TC BioPharm shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.